Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical Surrogates for Molecular Stratification in Medulloblastoma.

Applied immunohistochemistry & molecular morphology : AIMM - 1 Sept 2023

Chinnam Dheeraj, Saraswati Aastha, Jogunoori Swathi, Verma Aanchal, Kiran Tanvi, Salunke Pravin, Gupta Nalini, Kumar Narendra, Madan Renu, Radotra Bishan Dass, Gupta Kirti

Abstract excerpt

BACKGROUND: The WHO classification of central nervous system neoplasms (2016) recognized 4 histologic variants and genetically defined molecular subgroups within medulloblastoma (MB). Further, in the 2021 classification, new subtypes have been provisionally added within the existing subgroups reflecting the biological diversity. YAP1, GAB1, and β-catenin were conventionally accepted as surrogate markers to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Cerebellar Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Hedgehog Proteins

Share to Infant

Share to Medulloblastoma

Share to Young Adult

Source

Identifiers

PMID: 37471625
DOI: 10.1097/PAI.0000000000001143

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical Surrogates for Molecular Stratification in Medulloblastoma.PMID 37471625Read ↗

Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroupsSemantic proximity Read ↗

Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified ApproachSemantic proximity Read ↗

Medulloblastoma: WHO 2021 and BeyondSemantic proximity Read ↗

Update on the integrated histopathological and genetic classification of medulloblastoma – a practical diagnostic guidelineSemantic proximity Read ↗

Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.Semantic proximity Read ↗

Molecular subgroups of medulloblastoma: the current consensusSemantic proximity Read ↗

Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical PracticeSemantic proximity Read ↗

Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic InsightsSemantic proximity Read ↗

The molecular classification of medulloblastomaSemantic proximity Read ↗

Affordable panel of techniques for prediction of molecular classification of a series of medulloblastomas in a reference pediatric hospital in ColombiaSemantic proximity Read ↗

Signaling pathway and molecular subgroups of medulloblastoma.Semantic proximity Read ↗

Genetic Grouping of Medulloblastomas by Representative Markers in Pathologic DiagnosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.